2/3 of CEOs plan to continue 'contactless' business activity
By Kim, Jin-Gu | translator Alice Kang
22.01.03 06:19:56
가나다라
0
Dailypharm's 2022 New Year’s feature on industry CEOs’ business management strategies
75% of CEOs expect the “work restructuring to further accelerate”
66% of CEOs plan to “maintain·expand non-face-to-face business activities post-COVID-19 pandemic”
Three years into the COVID-19 pandemic, 3 out of 4 CEOs from pharmaceutical and biopharmaceutical companies expect their company’s non-face-to-face business activities to expand further this year.
The CEOs have also announced plans to maintain or reinforce their non-face-to-face business activities that settled as the ‘new normal’ in the industry over the past two years.
◆Non-face-to-face activities as the ‘new normal’… 75% of CEOs say such activities will “expand further this year"
According to a business strategy survey conducted by Dailypharm on 51 CEOs from pharmaceutical and biopharmaceutical companies, 75%(38) of the responders predicted that t
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)